Martin F Engelke

Dr. Martin F Engelke

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2011 in Cell Host & Microbe
Verified
Journal Article
Closed access
SSSten Strunze
Sten Strunze
MEMartin F Engelke
Martin F Engelke
IWI-Hsuan Wang
I-Hsuan Wang
DPDaniel Puntener
Daniel Puntener
KBKarin Boucke
Karin Boucke
UGUrs Greber
Urs Greber

1 January 2011 in Journal of Virology
Verified
Journal Article
Closed access
DPDaniel Puntener
Daniel Puntener
MEMartin F Engelke
Martin F Engelke
ZRZsolt Ruzsics
Zsolt Ruzsics
SSSten Strunze
Sten Strunze
CWCorinne Wilhelm
Corinne Wilhelm
UGUrs Greber
Urs Greber
Human adenoviruses (Ads) replicate and assemble particles in the nucleus. They organize a linear double-strand DNA genome into a condensed core with about 180 nucleosomes, by the viral proteins VII (pVII), pX, and pV attaching the DNA to the capsid. Using reverse genetics, we generated a novel, nonconditionally replicating Ad reporter by inserting green fluorescent protein (GFP) at the amino terminus of pV. Purified Ad2-GFP-pV virions had an oversized complete genome and incorporated about 38 GFP-pV molecules per virion, which is about 25% of the pV levels in Ad2. GFP-pV cofractionated with the DNA core, like pV, and newly synthesized GFP-pV had a subcellular localization indistinguishable from that of pV, indicating that GFP-pV is a valid reporter for pV. Ad2-GFP-pV completed the replication cycle, although at lower yields than Ad2. Incoming GFP-pV (or pV) was not imported into the nucleus. Virions lost GFP-pV at two points during the infection process: at entry into the cytosol and at the nuclear pore complex, where capsids disassemble. Disassembled capsids, positive for the conformation-specific antihexon antibody R70, were devoid of GFP-pV. The loss of GFP-pV was reduced by the macrolide antibiotic leptomycin B (LMB), which blocks nuclear export and adenovirus attachment to the nuclear pore complex. LMB inhibited the appearance of R70 epitopes on Ad2 and Ad2-GFP-pV, indicating that the loss of GFP-pV from Ad2-GFP-pV is an authentic step in the adenovirus uncoating program. Ad2-GFP-pV is genetically complete and hence enables detailed analyses of infection and spreading dynamics in cells and model organisms or assessment of oncolytic adenoviral potential.

1 April 2019 in Current Biology
Verified
Journal Article
Closed access
MEMartin F Engelke
Martin F Engelke
BWBridget Waas
Bridget Waas
SKSarah E. Kearns
Sarah E. Kearns
ASAyana Suber
Ayana Suber
ABAllison Boss
Allison Boss
KVKristen J. Verhey
Kristen J. Verhey

24 December 2009 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
MGMattia Gazzola
Mattia Gazzola
CBChristoph J. Burckhardt
Christoph J. Burckhardt
BBBasil Bayati
Basil Bayati
MEMartin F Engelke
Martin F Engelke
UGUrs Greber
Urs Greber
PKPetros Koumoutsakos
Petros Koumoutsakos
Cytoplasmic transport of organelles, nucleic acids and proteins on microtubules is usually bidirectional with dynein and kinesin motors mediating the delivery of cargoes in the cytoplasm. Here we combine live cell microscopy, single virus tracking and trajectory segmentation to systematically identify the parameters of a stochastic computational model of cargo transport by molecular motors on microtubules. The model parameters are identified using an evolutionary optimization algorithm to minimize the Kullback-Leibler divergence between the in silico and the in vivo run length and velocity distributions of the viruses on microtubules. The present stochastic model suggests that bidirectional transport of human adenoviruses can be explained without explicit motor coordination. The model enables the prediction of the number of motors active on the viral cargo during microtubule-dependent motions as well as the number of motor binding sites, with the protein hexon as the binding site for the motors. Molecular motors, due to their transportation function, are essential to the cell, but they are often hijacked by viruses to reach their replication site. Imaging of virus trajectories provides information about the patterns of virus transport in the cytoplasm, leading to improved understanding of the underlying mechanisms. In turn improved understanding may suggest actions that can be taken to interfere with the transport of pathogens in the cell. In this work we use in vivo imaging of virus trajectories to develop a computational model of virus transport in the cell. The model parameters are identified by an optimization procedure to minimize the discrepancy between in vivo and in silico trajectories. The model explains the in vivo trajectories as the result of a stochastic interaction between motors. Furthermore it enables predictions on the number of motors and binding sites on pathogens, quantities that are difficult to obtain experimentally. Beyond the understanding of mechanisms involved in pathogen transport, the present paper introduces a systematic parameter identification algorithm for stochastic models using in vivo imaging. The discrete and noisy characteristics of biological systems have led to increased attention in stochastic models and this work provides a methodology for their systematic development.

24 May 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
MRMadhu Sudhan Ravindran
Madhu Sudhan Ravindran
MEMartin F Engelke
Martin F Engelke
KVKristen J. Verhey
Kristen J. Verhey
BTBilly Tsai
Billy Tsai
Viruses exploit cellular machineries to penetrate a host membrane and cause infection, a process that remains enigmatic for non-enveloped viruses. Here we probe how the non-enveloped polyomavirus SV40 penetrates the endoplasmic reticulum (ER) membrane to reach the cytosol, a crucial infection step. We find that the microtubule-based motor kinesin-1 is recruited to the ER membrane by binding to the transmembrane J-protein B14. Strikingly, this motor facilitates SV40 ER-to-cytosol transport by constructing a penetration site on the ER membrane called a ‘focus’. Neither kinesin-2, kinesin-3 nor kinesin-5 promotes foci formation or infection. The specific use of kinesin-1 is due to its unique ability to select posttranslationally modified microtubules for cargo transport and thereby spatially restrict focus formation to the perinucleus. These findings support the idea of a ‘tubulin code’ for motor-dependent trafficking and establish a distinct kinesin-1 function in which a motor is exploited to create a viral membrane penetration site.

9 March 2011 in Viruses
Verified
Journal Article
Open access
PDF file
MEMartin F Engelke
Martin F Engelke
CBChristoph Burckhardt
Christoph Burckhardt
MMMatthias K. Morf
Matthias K. Morf
UGUrs Greber
Urs Greber
Unlike transport vesicles or organelles, human adenovirus (HAdV) directly binds to the microtubule minus end-directed motor dynein for transport to the nucleus. The dynein cofactor dynactin enhances nuclear transport of HAdV and boosts infection. To determine if dynactin has a specific role in cytoplasmic trafficking of incoming HAdV on microtubules, we used live cell spinning disc confocal microscopy at 25 Hz acquisition frequency and automated tracking of single virus particles at 20–50 nm spatial resolution. Computational dissection by machine-learning algorithms extracted specific motion patterns of viral trajectories. We found that unperturbed cells supported two kinds of microtubule-dependent motions, directed motions (DM) and fast drifts (FD). DM had speeds of 0.2 to 2 µm/s and run lengths of 0.4 up to 7 µm, while FD were slower and less extensive at 0.02 to 0.4 µm/s and 0.05 to 2.5 µm. Dynactin interference by overexpression of p50/dynamitin or a coiled-coil domain of p150/Glued reduced the speeds and amounts of both center- and periphery-directed DM but not FD, and inhibited infection. These results indicate that dynactin enhances adenovirus infection by increasing the speed and efficiency of dynein-mediated virus motion to the nucleus, and, surprisingly, also supports a hereto unknown motor activity for virus transport to the cell periphery.